Article
Accuracy of Modern Clinical Risk Score Including RAS Status Changes Based on Whether Patients Received Perioperative Chemotherapy for Colorectal Liver Metastases.
World journal of surgery - 1 Jul 2021
Takeda Yoshinori, Mise Yoshihiro, Matsumura Masaru, Hasegawa Kiyoshi, Yoshimoto Jiro, Imamura Hiroshi, Noro Takuji, Yamamoto Junji, Ishizuka Naoki, Inoue Yosuke, Ito Hiromichi, Takahashi Yu, Saiura Akio
Abstract excerpt
BACKGROUND: A modified Fong clinical score (m-Fong CS) that includes the RAS mutation status has recently been proposed and offered an improved survival stratification of patients who undergo surgery and systemic chemotherapy for colorectal liver metastases (CLM). The aim of this study is to assess whether a CS that includes RAS status is influenced by whether patients receive perioperative chemotherapy. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
